PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25226519-8	2014	Phospho-ERK activation was visibly blocked and the MMP-1, MMP-3, and MMP-13 mRNA and protein levels were lower than the corresponding levels in the CSD without U0126 group.	U 0126	160-165	matrix metallopeptidase 13	Rattus norvegicus	69-75	
22965193-6	2013	It was noted that HA + U0126 significantly reduced the levels of pERK, chondrocyte hypertrophic markers (COL10 and RUNX2) and degenerative markers (ADAMTs5 and MMP-13), however, increased the levels of chondrogenic markers (COL2) compared to untreated or the application of HA or U0126 alone.	U 0126	23-28	matrix metallopeptidase 13	Rattus norvegicus	160-166	
33939302-21	2021	In addition, ERK inhibitor U0126 treatment also decreased the TNF-alpha, IL-6, and IL-1betalevels and MMP-3, MMP-13, ADAMTS-5, ICAM-1, ERK and p-ERK expression in HG + IL-1beta treated rat synovial fibroblasts.	U 0126	27-32	matrix metallopeptidase 13	Rattus norvegicus	109-115